Clinical trial shows tile-based radiation therapy lowers risk of recurrence in brain metastases

byUniversity of Texas MD Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center has found that imp

Updated on: July 19,2026

Clinical trial shows tile-based radiation therapy lowers risk of recurrence in brain metastases

byUniversity of Texas MD Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center has found that imp

Updated on:July 19,2026

Creatine may supercharge immune cells that are key to fighting cancer

by Tiare Dunlap,University of California, Los AngelesAn artistic rendering of a human dendritic cell. Credit: Don Bliss & Sriram Subramaniam, National Cancer InstituteCreatine, the organic acid th

Updated on: August 19,2026

Creatine may supercharge immune cells that are key to fighting cancer

by Tiare Dunlap,University of California, Los AngelesAn artistic rendering of a human dendritic cell. Credit: Don Bliss & Sriram Subramaniam, National Cancer InstituteCreatine, the organic acid th

Updated on:August 19,2026

First‑in‑human study tests gamitrinib designed to disrupt cancer cells' energy systems

byTemple UniversityAnthony Olszanski, MD, RPh, Vice Chair of Clinical Research in the Department of Hematology/Oncology and Director of the Early Clinical Drug Development Phase 1 Program at Fox Chase

Updated on: July 28,2026

First‑in‑human study tests gamitrinib designed to disrupt cancer cells' energy systems

byTemple UniversityAnthony Olszanski, MD, RPh, Vice Chair of Clinical Research in the Department of Hematology/Oncology and Director of the Early Clinical Drug Development Phase 1 Program at Fox Chase

Updated on:July 28,2026

New study uncovers mechanism explaining how obesity increases cancer risk

by Zen Logsdon,City of Hope National Medical CenterCredit: beyzahzah from PexelsScientists at City of Hope and TGen (part of City of Hope) are the first to explain a major mechanism for why gaining ex

Updated on: June 16,2026

New study uncovers mechanism explaining how obesity increases cancer risk

by Zen Logsdon,City of Hope National Medical CenterCredit: beyzahzah from PexelsScientists at City of Hope and TGen (part of City of Hope) are the first to explain a major mechanism for why gaining ex

Updated on:June 16,2026

Triple pre-surgery therapy may boost immunity against soft tissue sarcoma

by Denise Heady,University of California, Los AngelesCredit: Pixabay/CC0 Public DomainEarly results from preclinical studies and a clinical trial led by researchers at the UCLA Health Jonsson Comprehe

Updated on: June 16,2026

Triple pre-surgery therapy may boost immunity against soft tissue sarcoma

by Denise Heady,University of California, Los AngelesCredit: Pixabay/CC0 Public DomainEarly results from preclinical studies and a clinical trial led by researchers at the UCLA Health Jonsson Comprehe

Updated on:June 16,2026

Targeted therapy reduces risk of lung cancer recurrence by 83% in rare genetic subtype

by Denise Heady,University of California, Los AngelesCredit: Pixabay/CC0 Public DomainA new study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center shows that the targeted

Updated on: August 20,2026

Targeted therapy reduces risk of lung cancer recurrence by 83% in rare genetic subtype

by Denise Heady,University of California, Los AngelesCredit: Pixabay/CC0 Public DomainA new study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center shows that the targeted

Updated on:August 20,2026

Worm tablet could be repurposed as brain cancer treatment

byBond UniversityBlood–brain barrier efflux limits brain penetration of mebendazole polymorph C, whereas elacridar increases central nervous system exposure. Credit:British Journal of Clinical Pharmac

Updated on: August 20,2026

Worm tablet could be repurposed as brain cancer treatment

byBond UniversityBlood–brain barrier efflux limits brain penetration of mebendazole polymorph C, whereas elacridar increases central nervous system exposure. Credit:British Journal of Clinical Pharmac

Updated on:August 20,2026

Serious infection risks linked to targeted cancer therapies

by Carly Murphy,University of California, IrvineCredit: Thirdman from PexelsA major real-world study by University of California, Irvine pharmacy researchers has found serious blood-related side effec

Updated on: August 20,2026

Serious infection risks linked to targeted cancer therapies

by Carly Murphy,University of California, IrvineCredit: Thirdman from PexelsA major real-world study by University of California, Irvine pharmacy researchers has found serious blood-related side effec

Updated on:August 20,2026

Blood test spots 14 proteins that predict lung cancer risk up to five years early

byThe Francis Crick InstituteGraphical abstract. Credit:Cell(2026). DOI: 10.1016/j.cell.2026.05.005As we age, our cells acquire cancer-causing mutations, but mutations alone are rarely enough to start

Updated on: August 19,2026

Blood test spots 14 proteins that predict lung cancer risk up to five years early

byThe Francis Crick InstituteGraphical abstract. Credit:Cell(2026). DOI: 10.1016/j.cell.2026.05.005As we age, our cells acquire cancer-causing mutations, but mutations alone are rarely enough to start

Updated on:August 19,2026

Study finds 10-plus genetic markers tied to early follicular lymphoma relapse

byUniversity of MissouriFollicular lymphoma (FL) is a type of blood cancer and a form of non-Hodgkin's lymphoma. Thanks to new treatment breakthroughs, about 80% of FL patients have a survival rat

Updated on: June 18,2026

Study finds 10-plus genetic markers tied to early follicular lymphoma relapse

byUniversity of MissouriFollicular lymphoma (FL) is a type of blood cancer and a form of non-Hodgkin's lymphoma. Thanks to new treatment breakthroughs, about 80% of FL patients have a survival rat

Updated on:June 18,2026

Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainPreviously, immature overall survival results of the NRG Oncology GY018 (NRG-GY018) trial suggested that the use of the immunotherapy drug pembrolizumab

Updated on: August 06,2026

Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainPreviously, immature overall survival results of the NRG Oncology GY018 (NRG-GY018) trial suggested that the use of the immunotherapy drug pembrolizumab

Updated on:August 06,2026

Study reveals asbestos blind spot in lung cancer screening may cost lives

by Laura Thomas,Curtin UniversityCredit: Sonny Sixteen from PexelsNew Curtin University research has found Australians exposed to asbestos could be falling through the cracks of lung cancer screening

Updated on: August 18,2026

Study reveals asbestos blind spot in lung cancer screening may cost lives

by Laura Thomas,Curtin UniversityCredit: Sonny Sixteen from PexelsNew Curtin University research has found Australians exposed to asbestos could be falling through the cracks of lung cancer screening

Updated on:August 18,2026